Skip to main content

Articles

Page 1 of 344

  1. The characteristics of a tumor are largely determined by its interaction with the surrounding micro-environment (TME). TME consists of both cellular and non-cellular components. Cancer-associated fibroblasts (...

    Authors: Apoorva Abikar, Mohammad Mehaboob Subhani Mustafa, Radhika Rajiv Athalye, Namratha Nadig, Ninad Tamboli, Vinod Babu, Ramaiah Keshavamurthy and Prathibha Ranganathan
    Citation: BMC Cancer 2024 24:1231
  2. Radiotherapy has both immunostimulant and immunosuppressive effects, particularly in radiation-induced lymphopenia. Proton therapy has demonstrated potential in mitigating this lymphopenia, yet the mechanisms ...

    Authors: Juliette Thariat, Thao-Nguyen Pham, Julie Coupey, Benedicte Clarisse, Jean-Michel Grellard, Nathalie Rousseau, Mathieu Césaire and Samuel Valable
    Citation: BMC Cancer 2024 24:1230
  3. To evaluate the diagnostic efficacy of a deep learning (DL) model based on PET/CT images for distinguishing and predicting various pathological subtypes of invasive lung adenocarcinoma.

    Authors: Dongbo Wu, Yingci Li, Mingyan Zhou, Feifei Gong and Jiankun Li
    Citation: BMC Cancer 2024 24:1229
  4. In locally advanced, operable esophageal squamous cell carcinoma (ESCC), neoadjuvant immunochemotherapy (nICT) has shown results that are somewhat comparable to those of standard neoadjuvant chemoradiotherapy ...

    Authors: Yi Wang, Ke Ma, Huan Zhang, Lei Wu, Li Liu, Yehan Zhou, Lin Peng, Qifeng Wang and Xiang Zhuang
    Citation: BMC Cancer 2024 24:1228
  5. In recent years, the addition of cetuximab to chemotherapy has improved treatment outcomes for patients with recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC). In this study, we present th...

    Authors: Muh-Hwa Yang, Tien-Hua Chen, Hung-Ming Wang, Jason Chia-Hsun Hsieh, Huai-Cheng Huang, Meng-Che Hsieh, Chia-Jui Yen, Shang-Yin Wu, Chun-Hung Hua, Ming-Yu Lien, Yi-Fang Chang, Hui-Ching Wang, Chih-Yen Chien, Tai-Lin Huang, Hsueh-Ju Lu, Jin-Ching Lin…
    Citation: BMC Cancer 2024 24:1227
  6. Colon cancer, a frequently encountered malignancy, exhibits a comparatively poor survival prognosis. Perineural invasion (PNI), highly correlated with tumor progression and metastasis, is a substantial effecti...

    Authors: Tairan Guo, Bing Cheng, Yunlong Li, Yaqing Li, Shaojie Chen, Guoda Lian, Jiajia Li, Ming Gao, Kaihong Huang and Yuzhou Huang
    Citation: BMC Cancer 2024 24:1226
  7. In recent years, clinicians often encounter patients with multiple pulmonary nodules in their clinical practices. As most of these ground glass nodules (GGNs) are small in volume and show no spicule sign, it i...

    Authors: Xiaodan Zhu, Changxing Shen and Jingcheng Dong
    Citation: BMC Cancer 2024 24:1225
  8. The role of diet in breast cancer prevention is controversial and limited in low-middle-income countries (LMICs). This study aimed to investigate the association between different dietary factors and breast ca...

    Authors: Tam M. Do, Quynh H. N. Nguyen, Nguyen H. D. Le, Hien D. Nguyen, An H. T. Phung, Thach S. Tran, Tuan V. Nguyen and Lan T. Ho-Pham
    Citation: BMC Cancer 2024 24:1224
  9. To compare the differences in long-term quality of life (QoL) between survivors of paediatric and adult patients with nasopharyngeal carcinoma (NPC) and assess the clinical factors that predict long-term QoL.

    Authors: Jing Jin, Shan-Shan Guo, Li-Ting Liu, Dong-Xiang Wen, Rong-Ping Liu, Jie-Yi Lin, Si-Qi Liu, Xue-Song Sun, Yu-Jing Liang, Lin-Quan Tang, Hai-Qiang Mai and Qiu-Yan Chen
    Citation: BMC Cancer 2024 24:1223
  10. Breast cancer (BC) is the most common cancer in women and poses a significant health burden, especially in China. Despite advances in diagnosis and treatment, patient variability and limited early detection co...

    Authors: Haodi Ma, LinLin Shi, Jiayu Zheng, Li Zeng, Youyou Chen, Shunshun Zhang, Siya Tang, Zhifeng Qu, Xin Xiong, Xuewei Zheng and Qinan Yin
    Citation: BMC Cancer 2024 24:1222
  11. Immunotherapy with anti-PD-1 antibodies significantly improved the prognosis in advanced melanoma patients, but most of them develop primary or secondary resistance to the treatment. In this study, we evaluate...

    Authors: Francesca Romana Di Pietro, Daniele Marinelli, Sofia Verkhovskaia, Giulia Poti, Rosa Falcone, Maria Luigia Carbone, Maria Francesca Morelli, Albina Rita Zappalà, Zorika Christiana Di Rocco, Roberto Morese, Gabriele Piesco, Paolo Chesi, Paolo Marchetti, Cristina Maria Failla and Federica De Galitiis
    Citation: BMC Cancer 2024 24:1220
  12. The study evaluated the prognostic impact of the immune microenvironment in LSCC with markers of major immune cells to identify the key determinants of short-term disease-free survival (ST DFS) and reveal fact...

    Authors: Anna Rzepakowska, Joanna Olędzka, Piotr Daniel, Marta Mękarska, Michał Żurek, Karol Kulbaka and Łukasz Fus
    Citation: BMC Cancer 2024 24:1219
  13. Despite initial dramatic responses, metastatic small cell lung cancer (SCLC) invariably recurs. Irinotecan is one of the active agents for patients with recurrent SCLC. In the second line, weekly or three-week...

    Authors: Feride Yılmaz, Serkan Yaşar, Ömer Denizhan Tatar, Hasan Çağrı Yıldırım, Deniz Can Güven, Arif Akyıldız, Elvin Chalabiyev, Burak Yasin Aktaş, Zafer Arık and Mustafa Erman
    Citation: BMC Cancer 2024 24:1218
  14. In this study, we evaluated the molecular mechanisms of HuangQiSiJunZi Decoction (HQSJZD) for treating triple-negative breast cancer (TNBC) using network pharmacology and bioinformatics analyses.

    Authors: Decai Wang, Dongqing Xie, Shuai Meng, Jiwei MI, Haiming Wang, Lingsheng Li, Yin Zhang and Yixin Cui
    Citation: BMC Cancer 2024 24:1217
  15. Different hormone receptor (HR) expression patterns have significant biological and therapeutic implications in patients with human epidermal growth factor receptor 2 (HER2)-positive breast cancer. However, th...

    Authors: Ran Ran, Shidi Zhao, Yan Zhou, Xinyue Hang, Hui Wang, Yuan Fan, Yusi Zhang, Yifan Qiao, Jin Yang and Danfeng Dong
    Citation: BMC Cancer 2024 24:1216
  16. Heterogeneity of hepatocellular carcinoma (HCC) presents significant challenges for therapeutic strategies and necessitates combinatorial treatment approaches to counteract suppressive behavior of tumor microe...

    Authors: Aydin Eresen, Zigeng Zhang, Guangbo Yu, Qiaoming Hou, Zhilin Chen, Zeyang Yu, Vahid Yaghmai and Zhuoli Zhang
    Citation: BMC Cancer 2024 24:1215
  17. Pre-clinical data suggests a potential synergistic effect of eribulin and platinum. However, clinical data on the combination for metastatic breast cancer (mBC) is lacking. We evaluated the efficacy and safety...

    Authors: Mengqian Ni, Lijia Zhou, Yongkui Lu, Dachuan Guo, Xiuyue Li, Lixia Li, Lidong Zhang, Meiting Chen, Lulu Zhang, Fei Xu, Zhongyu Yuan, Shusen Wang, Yanxia Shi, Anli Yang and Xin An
    Citation: BMC Cancer 2024 24:1214
  18. The main challenge in treating ovarian cancer is chemotherapy resistance. Previous studies have shown that PAK2 is highly expressed in various cancers. This research investigates whether increased PAK2 express...

    Authors: Ting Shuang, Shiyun Wu, Yifei Zhao, Yanqi Yang and Meili Pei
    Citation: BMC Cancer 2024 24:1213
  19. Uganda is a developing low-income country with a low incidence of colorectal cancer, which is steadily increasing. Ugandan colorectal cancer (CRC) patients are young and present with advanced-stage disease. In...

    Authors: Richard Wismayer, Rosie Matthews, Celina Whalley, Julius Kiwanuka, Fredrick Elishama Kakembo, Steve Thorn, Henry Wabinga, Michael Odida and Ian Tomlinson
    Citation: BMC Cancer 2024 24:1212
  20. In hepatocellular carcinoma (HCC) treatment, first-line targeted therapy in combination with immune checkpoint inhibitors (ICIs) has improved patient prognosis, but the 5-year survival rate is far from satisfa...

    Authors: Yang Shen, Jiayu Chen, Zhuolin Zhou, Jingyu Wu, Xinyao Hu, Yangtao Xu, Jiayi Li, Ling Wang, Siyu Wang, Shuhong Yu, Ling Feng and Ximing Xu
    Citation: BMC Cancer 2024 24:1211
  21. Fluoropyrimidines are chemotherapy drugs utilized to treat a variety of solid tumors. These drugs predominantly rely on the enzyme dihydropyrimidine dehydrogenase (DPD), which is encoded by the DPYD gene, for ...

    Authors: Francisco Cezar Aquino de Moraes, Alícia Batista de Almeida Barbosa, Vitor Kendi Tsuchiya Sano, Francinny Alves Kelly and Rommel Mario Rodriguez Burbano
    Citation: BMC Cancer 2024 24:1210
  22. Sexual dysfunction is a social challenge that devastates many people, including cancer patients. However, among the numerous reported side effects of chemotherapy sexual dysfunction is the least studied and re...

    Authors: Joel Nyanchiri Oenga, Robert Tamukong, John Isiiko, Sibali Gidimali Gibu, Kule Gidion and Tadele Mekuriya Yadesa
    Citation: BMC Cancer 2024 24:1209
  23. Gastric cancer (GC), a molecularly heterogeneous disease, is the third leading cause of cancer death worldwide. The majority of GC cases worldwide occur in East Asia, predominantly China. Mutational Signature ...

    Authors: Fatao Liu, Nan Hu, Kewei Jiang, Huaitian Liu, Mingyi Wang, Ying Hu, Tongwu Zhang, Ho-Hsiang Wu, Howard Yang, Hao Weng, Ping Dong, Carol Giffen, Bin Zhu, Maxwell P. Lee, Christian C. Abnet, Philip R. Taylor…
    Citation: BMC Cancer 2024 24:1208
  24. Synthetic data may proxy clinical data. At the absence of direct clinical data, this study aimed to compare Irinotecan and Ifosfamide (II) with Topotecan in synthetic, recurrent small cell lung cancer (SCLC) p...

    Authors: Hakan Şat Bozcuk and Mehmet Artaç
    Citation: BMC Cancer 2024 24:1207
  25. Patients with extensive-stage small cell lung cancer (ES-SCLC) experience significant therapeutic challenges and limited survival rates. This study aimed to investigate the efficacy of combining immunotherapy ...

    Authors: Meiling Sun, Huaijun Ji, Fang Deng, Jingyi Li, Ning Xu and Yu Li
    Citation: BMC Cancer 2024 24:1206
  26. Colorectal cancer is one of the most common cancers worldwide. DNA methylation sites may serve as a new gene signature for colorectal cancer diagnosis. The search for representative DNA methylation sites is ur...

    Authors: Yue Liu, Hongbo Ming, Lizhi Xu, Lizhen Li, Qi Liu, Jinyin Zhao, Cundi Zhong and Hongzhi Li
    Citation: BMC Cancer 2024 24:1205
  27. With the development of novel anti-HER2 targeted drugs, such as ADCs, it has become increasingly important to accurately interpret HER2 expression in breast cancer. Previous studies have demonstrated high intr...

    Authors: Zhongtang Xiong, Kai Liu, Shaoyan Liu, Jiahao Feng, Jin Wang, Zewen Feng, Boan Lai, Qingxin Zhang, Qingping Jiang and Wei Zhang
    Citation: BMC Cancer 2024 24:1204
  28. The biological function of ZYG11B is still unclear, and few studies on ZYG11B in colorectal cancer were reported. The purpose of our research is to detect the biological functions of ZYG11B in colorectal cance...

    Authors: Jinchi Zhou, Mengmeng Cui, Junrong Liang, Jing Zhao and Yanjie Guo
    Citation: BMC Cancer 2024 24:1203
  29. Tumour microenvironment (TME) of breast cancer mainly comprises malignant, stromal, immune, and tumour infiltrating lymphocyte (TILs). Assessment of TILs is crucial for determining the disease’s prognosis. Man...

    Authors: Nurkhairul Bariyah Baharun, Afzan Adam, Mohamed Afiq Hidayat Zailani, Nasir M. Rajpoot, Qiaoyi XU and Reena Rahayu Md Zin
    Citation: BMC Cancer 2024 24:1202
  30. Breast cancer (BC) is the most common cancer in women worldwide. Early diagnosis of BC could considerably improve outcomes. Since health literacy could influence preventive behaviors and women’s ability to mak...

    Authors: Sedighe Rezaie-Chamani, Minoor Lamyian, Fazlollah Ahmadi and Ali Montazeri
    Citation: BMC Cancer 2024 24:1201
  31. Acute promyelocytic leukemia (APL) is the sub-type of Acute myeloid leukemia (AML) which is described by differentiation block at promyelocytic stage and t(15; 17) translocation with All trans retinoic acid (A...

    Authors: Bazla Binte Nadeem, Aysha Bibi, Mudassir Khan, Gul Rukh Sajjad, Fazal Adnan, Zaheer Ahmad and Dilawar Khan
    Citation: BMC Cancer 2024 24:1200
  32. Colorectal cancer, a prevalent malignancy worldwide, poses a significant challenge due to the lack of effective prognostic tools. In this study, we aimed to develop a functional gene signature to stratify colo...

    Authors: Ziyan Zhu, Jikun Li, Zhenzhong Fa, Xuezhong Xu, Yue Wang, Jie Zhou and Yixin Xu
    Citation: BMC Cancer 2024 24:1199
  33. A dosimetric evaluation is still lacking in terms of clinical target volume (CTV) omission in stage III patients treated with 4D-CT Intensity-Modulated Radiation Therapy (IMRT).

    Authors: Wenxin Ding, Tian Xu, Hui Xiang, Jing Liang, Weiwei Liang, Nan Xiang, Jingsheng Zhao, Guoyin Li and Zewen Song
    Citation: BMC Cancer 2024 24:1198
  34. Physiologic MRI-based tumor habitat analysis has the potential to predict patient outcomes by identifying the spatiotemporal habitats of glioblastoma. This study aims to prospectively validate the cut-off for ...

    Authors: Hye Hyeon Moon, Ji Eun Park, NakYoung Kim, Young-Hoon Kim, Sang Woo Song, Chang Ki Hong, Jeong Hoon Kim and Ho Sung Kim
    Citation: BMC Cancer 2024 24:1197
  35. Lung cancer (LC) is the most common cancer among males and the third most common cancer among females worldwide. Focusing on primary prevention may be the main strategy for reducing the overall mortality of LC...

    Authors: Fatemeh Toorang, Monireh Sadat Seyyedsalehi, Bahareh Sasanfar, Hamideh Rashidian, Maryam Hadji, Mahin Gholipour, Maryam Marzban, Mahdieh Bakhshi, Abbas Rezaianzadeh, Paolo Boffetta and Kazem Zendehdel
    Citation: BMC Cancer 2024 24:1196
  36. Robot-assisted radical prostatectomy (RARP) gains increasing popularity in the surgical management of prostate cancer (PCa) but is challenged by its prohibitive expense. A domestic robotic system has been deve...

    Authors: Jie Dong, Ruoyu Ji, Liang Cui, Guanghua Liu, Yi Xie, Jingmin Zhou, Huizhen Wang, Weifeng Xu and Zhigang Ji
    Citation: BMC Cancer 2024 24:1194
  37. Combining immune checkpoint and proton pump inhibitors is widely used in cancer treatment. However, the drug-drug interactions of these substances are currently unknown. This study aimed to explore drug-drug i...

    Authors: Xiayang Ren, Lu Li, Yiran Chen, Xiangli Cui, Rui Wan and Yanfeng Wang
    Citation: BMC Cancer 2024 24:1193
  38. The association between gallstones/cholecystectomy and cancer remains inconclusive in the current literature. This study aimed to explore the causal connections between gallstones/cholecystectomy and cancer ri...

    Authors: Fei Teng, Youyin Tang, Zhangyu Lu, Kefei Chen and Zheyu Chen
    Citation: BMC Cancer 2024 24:1192
  39. Identifying primary hepatic angiosarcoma (PHA) preoperatively is challenging, often relying on postoperative pathology. Invasive biopsy increases bleeding risk, emphasizing the importance of early PHA diagnosi...

    Authors: Lei Jiang, Lijun Xie, Zhenheng Wu, Qiming Ke, Mo Chen, Wei Pan, Fuxiu Zhong, Haijie Hong, Jiangzhi Chen, Xinran Cai, Shun Chen, Ling Gan and Yanling Chen
    Citation: BMC Cancer 2024 24:1191
  40. Immune checkpoint inhibitors (ICIs) have become the recommended first-line treatment for advanced non-small cell lung cancer (NSCLC) without driver gene mutations. However, data on the failure patterns of firs...

    Authors: Jia-Yi Deng, Ming-Yi Yang, Xiao-Rong Yang, Zhi-Hong Chen, Chong-Rui Xu and Qing Zhou
    Citation: BMC Cancer 2024 24:1190
  41. Independent and valid prognostic predictors for locally advanced gastric cancer (LAGC) patients with non-elevated serum tumor markers (Triple-negative: CA199 < 37U/ml, CEA < 5 µg/ml and CA125 < 35U/ml) before ...

    Authors: Hua-Long Zheng, Ling-Kang Zhang, Chen-Bin Lv, Bin-Bin Xu, Jian-Xian Lin, Chao-Hui Zheng, Chang-Ming Huang and Jian-Wei Xie
    Citation: BMC Cancer 2024 24:1188
  42. N6-methyladenosine (m6A) is a prevalent mRNA modification known for its implications in various cancer types, yet its role in chromophobe renal cell carcinoma (chRCC) remains largely unexplored. In this study, we...

    Authors: Zhigang Chen, Junbo Yang, Wei Zhang, Yang Qian, Nan Zhang, Zixin Chen, Min Lu, Liyuan Ge, Cheng Liu, Xiaojun Tian, Guifang Jia, Lulin Ma and Baoguo Li
    Citation: BMC Cancer 2024 24:1187
  43. Breast cancer is the most common malignancy among women in the UK. Reconstruction – of which implant-based breast reconstruction (IBBR) is the most common – forms a core part of surgical management of breast c...

    Authors: Hannah I. Cook, Sevasti P. Glynou, Sara Sousi, David Zargaran, Stephen Hamilton and Afshin Mosahebi
    Citation: BMC Cancer 2024 24:1186
  44. The occurrence of complications following radical gastrectomy for gastric cancer significantly impacts patients’ quality of life. Elderly patients are susceptible to postoperative complications. This study see...

    Authors: Zhe-kui Liu, Wen-xing Ma, Jun-jie Zhang, Si-da Liu, Xiang-long Duan and Ze-zheng Wang
    Citation: BMC Cancer 2024 24:1185
  45. Teaching effective methods for breast self-examination (BSE) to adolescent females is essential for promoting early detection and improving outcomes in breast cancer management. This study therefore aimed to c...

    Authors: Eunice Oluwakemi Ogunmodede, Dolapo Emmanuel Ajala, Joel Ojo Aluko, Rafiat Ajoke Anokwuru, Titilope Abisola Awotunde, Adetunmise Oluseyi Olajide, Taiwo Omotayo Dosumu, Oluwaseyi Isaiah Olabisi and Ronke Gbonjubola Ajala
    Citation: BMC Cancer 2024 24:1183
  46. To establish the pathological diagnosis of UTUC before treatment is profitable. At present, the conventional pathological diagnostic methods have certain problems. Besides, the urine-based DNA methylation test...

    Authors: Wei Wei, Panhong Fan, Zhishu Zhang, Danting Wu, Junfeng Liu, Lingdian Wang, Xiaoyu Duan, Xiaoli Zhang and Degang Ding
    Citation: BMC Cancer 2024 24:1180
  47. Several inflammatory indicators have been reported to have predictive value in many types of malignant cancer. This research was aimed to explore the ability of the monocyte-to-lymphocyte ratio (MLR) to predic...

    Authors: Bin-Feng Tao, Hai-Qiang Zhu, Lu-Nan Qi, Jian-Hong Zhong, Rong-yun Mai and Liang Ma
    Citation: BMC Cancer 2024 24:1179
  48. The brachytherapy (BT) and radical prostatectomy (RP) are two methods recommended in current guidelines for the treatment of localized prostate cancer (PCa). It is difficult to compare the oncological results ...

    Authors: Zaisheng Zhu, Yiyi Zhu, Hongqi Shi, Penfei Zhou, Yadong Xue, Ke Dong and Shengye Hu
    Citation: BMC Cancer 2024 24:1177
  49. To develop radiomics models based on multi-sequence MRI from two centers for the preoperative prediction of the WHO/ISUP grade of Clear Cell Renal Cell Carcinoma (ccRCC).

    Authors: Ruihong Chen, Qiaona Su, Yangyang Li, Pengxin Shen, Jianxin Zhang and Yan Tan
    Citation: BMC Cancer 2024 24:1176

Featured videos

View featured videos from across the BMC-series journals